Nicola Magrini, Unit head for Innovation, Evidence synthesis and Clinical research, University Hospital, Bologna, Italy, Co-Chair of the Guidelines Development Group Comments: GLP-1 and inclusion in the essential medicine Mr Deus Mubangizi, Director, Medicines and Health Products Policies and Standards Department, WHO Panel discussion Ms Jeanette Hunter General Primary Health Care at the National Department of Health (NDoH) of South Africa, and Co-Chair of the Guidelines Development Group
It's signaling it needs deeper support
Hygum K, Starup-Linde J, Langdahl BL
Individual metabolic characteristics, including baseline insulin sensitivity, body mass index, and the presence of prediabetes or type 2 diabetes, appear to influence incretin hormone secretion patterns
Wegovy injection (semaglutide 2.4 mg, weekly): around 15% average weight loss over 68 weeks in the STEP 1 trial when combined with lifestyle support
Always have a fire extinguisher nearby when charging